Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

96 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this survey was to retrospectively collect and evaluate the information on the efficacy and safety of PAXIL tablets ("PAXIL", hereinafter) in pediatric subjects (aged under 18) with panic disorder under conditions of actual use.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

NCT01371474

Panic Disorder

COMPLETED

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

NCT01376271

Social Phobia

COMPLETED

Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy

NCT00121888

Stress Disorders, Post-Traumatic

COMPLETED PHASE1/PHASE2

Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression

NCT00031317

Panic Disorder

COMPLETED PHASE4

A Study in Pediatric Participants With Generalized Anxiety Disorder

NCT01226511

Anxiety Neuroses Anxiety States, Neurotic Neuroses, Anxiety

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Panic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects prescribed PAXIL

Pediatric subjects with panic disorder prescribed PAXIL during study period

Paroxetine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paroxetine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged under 18 at the time of the panic disorder diagnosis
* Aged under 18 on the starting day of PAXIL treatment
* Having been making periodic visits to the hospital to receive treatment for panic disorder

Exclusion Criteria

* Subjects who have been treated with paroxetine prior to this investigation
* Subjects with hypersensitivity to paroxetine
* Subjects taking monoamine oxidase inhibitors (MAOIs) or within 2 weeks of stopping treatment with MAOIs
* Concomitant use in patients taking pimozide

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No